SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?


To: Joe Copia who wrote (21899)3/20/2000 12:27:00 PM
From: Joe Copia  Read Replies (1) | Respond to of 25711
 
buying IMXN $1.50 news:

Monday March 20, 12:00 pm Eastern Time

Company Press Release

SOURCE: IMX Pharmaceuticals, Inc.

IMX Pharmaceuticals, Inc. and iVillage.com Announce Distribution Agreement For Mother2Be(TM) Skin Care for Pregnancy and Beyond

BOCA RATON, Fla. and NEW YORK, March 20 /PRNewswire/ -- IMX Pharmaceuticals, Inc. (OTC Bulletin Board: IMXN - news) and iVillage Inc. (Nasdaq: IVIL - news) today announced an
agreement between IMX Pharmaceuticals' wholly owned subsidiary Sarah J, Inc. and iBaby.com, a subsidiary of iVillage Inc., for distribution of Mother2Be(TM), IMX's prestige line of safe, natural and effective pregnancy skin and body care treatments designed to soothe, heal and protect an expectant mother's skin.

``Distribution of Mother2Be at iVillage.com enables us to be part of the dominant player in the women's online market,' stated Marc Falkin, Senior Vice President of IMX Pharmaceuticals, Inc.

``It is a great step towards the growth of our company and we are proud to support this agreement.'

``iBaby.com continues to deliver the best products for mother and baby,' said Deborah Kogan, Vice-President Commerce at iBaby.com. ``And now, visitors to iBaby.com and iVillage.com will have access to a prestige line of skin care treatments to help address their skin care concerns during and after pregnancy.'

About iVillage: The Women's Network

iVillage.com: The Women's Network (http://www.ivillage.com and AOL keyword: ivillage) is the leading women's network online providing practical solutions and everyday support for women between the ages of 25 and 54. iVillage.com is organized into branded communities that focus on issues of most importance to women and provide interactive services, peer support and online access to experts through 16 content channels and shopping areas. Content channels include Parent Soup, allHealth, MoneyLife, Career, Work from Home, Relationships, Beauty, Diet & Fitness, Election 2000, Click!: Where Computers Make Sense, Pets, Travel, ParentsPlace, Food, Book Club and Astrology, and are complemented by stores such as iBaby and iMaternity and Shopping Central.

Established in 1995 and headquartered in New York City, iVillage Inc. is a new media company, recognized as an industry leader in developing innovative sponsorship and commerce relationships that match the desire of marketers to reach women with the needs of iVillage.com members for
relevant information and services.

About IMX Pharmaceuticals

IMX Pharmaceuticals, Inc. develops over-the-counter pharmaceutical products formulated under their proprietary licenses that deliver superior benefits in the treatment of skin care. The Company's wholly owned subsidiary, Sarah J, Inc., distributes Mother2Be(TM), a line of safe, natural and
effective pregnancy skin and body care products designed to soothe, heal and protect an expectant mother's skin, mother2be.com. Podiatrx, Inc., and Proctozone, Inc., wholly-owned subsidiaries of IMX, are finalizing the release dates of PODIATRx(TM), a line of new medications
for various foot ailments, and Proctozone(TM) a new line of medications for various anal-rectal ailments.

For more information about IMX Pharmaceuticals call 561-998-5660 or visit the IMX website at
imxn.com .

For more information about Ivillage, Inc. visit the iVillage website at ivillage.com .

Except for historical information, this news release may contain certain forward-looking statements
that involve risks and uncertainties which may cause actual results to differ materially from the
statements made, including the companies' dependence on sales of key products, uncertainty of
future financial results and fluctuations in operating results, dependence on the companies' acquisition
strategy, new product introductions and other risks. These forward-looking statements represent the
judgment of the company, as of the date of this release, and the company disclaims any intent or
obligation to update these forward-looking statements.

SOURCE: IMX Pharmaceuticals, Inc.



To: Joe Copia who wrote (21899)3/20/2000 3:52:00 PM
From: PROLIFE  Read Replies (1) | Respond to of 25711
 
SEVT need a PR firm?